Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells-Reference-Cited by-同舟云学术

Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells

Published:2020-03-06 Issue:1 Volume:31 Page:64-78
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Varshosaz Jaleh¹^ORCID,Jandaghian Setareh¹,Mirian Mina²,Sajjadi S. Ebrahim³

Affiliation:

1. Novel Drug Delivery Systems Research Center, Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

2. Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

3. Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Funder

Isfahan University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2020.1720718

Reference61 articles.

1. Characterization and Stability of Nanostructured Lipid Carriers as Drug Delivery System

2. A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line

3. Exploitation of redox discrepancy in leukemia cells by a reactive oxygen species nanoscavenger for inducing cytotoxicity in imatinib resistant cells

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytocompounds and Nanoformulations for Anticancer Therapy: A Review;Molecules;2024-08-09

2. A Critical Review on the Bioavailability Promotion of the Food Bioactive Compounds: Nano Lipid Carriers Perspective;Pharmaceutical Sciences;2024-06-11

3. Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights;Nanomaterials;2024-04-12

4. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles;Life;2024-04-10

5. Curcumin in treatment of hematological cancers: Promises and challenges;Journal of Traditional and Complementary Medicine;2024-03